Assessing physician preferences on future therapeutic options and diagnostic practices in non-alcoholic steatohepatitis

by Nigel Cook, Andreas Geier, Andreas Schmid, Gideon Hirschfield, Achim Kautz, Jörn M. Schattenberg, Maria-Magdalena Balp
Published 2020-04-01

The Patient Perspectives on Future Therapeutic Options in NASH and Patient Needs

by Nigel Cook, Andreas Geier, Andreas Schmid, Gideon Hirschfield, Achim Kautz, Jörn M. Schattenberg, Maria-Magdalena Balp
Published 2019-04-01

The global epidemiology of nonalcoholic steatohepatitis (NASH) and associated risk factors–A targeted literature review

by Jean-François Dufour, Roger Scherer, Maria-Magdalena Balp, Sarah Jane McKenna, Nico Janssens, Patricia Lopez, Marcos Pedrosa
Published 2021-06-01

The burden of non-alcoholic steatohepatitis (NASH) among patients from Europe: A real-world patient-reported outcomes study

by Maria-Magdalena Balp, Nancy Krieger, Raymond Przybysz, Nate Way, Jennifer Cai, Dion Zappe, Sarah Jane McKenna, Garth Wall, Nico Janssens, Elliot Tapper
Published 2019-09-01

Health-related quality of life and patient-reported outcome measures in NASH-related cirrhosis

by Lorraine McSweeney, Matthew Breckons, Gulnar Fattakhova, Yemi Oluboyede, Luke Vale, Laura Ternent, Maria-Magdalena Balp, Lynda Doward, Clifford A. Brass, Fiona Beyer, Arun Sanyal, Quentin M. Anstee
Published 2020-06-01